Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 22c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $84.5 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
• Strategy (MSTR) call put ratio 2.1 calls to 1 put with a focus on August 28 weekly calls as share price up 5.1%
• SPDR Gold Trust (GLD) spreader of 115,876 contracts of September 420 and 430 calls as share price up 1.22%